---
title: "Competition concerns put Edwards’ JenaValve acquisition in jeopardy"
date: "2025-08-07T08:44:37.000Z"
publishedDate: "7 août 2025"
summary: "The US Federal Trade Commission (FTC) has moved to block Edwards Lifesciences’ proposed acquisition of its competitor transcatheter aortic valve implantation (TAVI) device developer JenaValve due to concerns that the acquisition would limit access to devices for the treatment of aortic regurgitation (AR). JenaValve is the developer of the Trilogy TAVI system, a transfemoral TAVI [&#8230;] The post Competition concerns put Edwards’ JenaValve acquisition in jeopardy appeared first on Cardiovascular News ."
importance: ""
sourceUrl: "https://cardiovascularnews.com/competition-concerns-put-edwards-jenavalve-acquisition-in-jeopardy/"
tags: ["France", "Actualité", "Cardiovascular News — Latest"]
permalink: "/papers/2025-08-07-competition-concerns-put-edwards-jenavalve-acquisition-in-jeopardy"
imageUrl: "http://cardiovascularnews.com/wp-content/uploads/sites/14/2024/12/trilogyhero-v2-1.jpg"
imageCredit: "Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/competition-concerns-put-edwards-jenavalve-acquisition-in-jeopardy/"
---

![Competition concerns put Edwards’ JenaValve acquisition in jeopardy](http://cardiovascularnews.com/wp-content/uploads/sites/14/2024/12/trilogyhero-v2-1.jpg)

*Crédit image : Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/competition-concerns-put-edwards-jenavalve-acquisition-in-jeopardy/*

## L’essentiel

The US Federal Trade Commission (FTC) has moved to block Edwards Lifesciences’ proposed acquisition of its competitor transcatheter aortic valve implantation (TAVI) device developer JenaValve due to concerns that the acquisition would limit access to devices for the treatment of aortic regurgitation (AR). JenaValve is the developer of the Trilogy TAVI system, a transfemoral TAVI [&#8230;] The post Competition concerns put Edwards’ JenaValve acquisition in jeopardy appeared first on Cardiovascular News .

## Lien source

https://cardiovascularnews.com/competition-concerns-put-edwards-jenavalve-acquisition-in-jeopardy/
